Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?

By Deng Lijuan   Song Yuqin   Zhu Jun   Zheng Wen   Wang Xiaopei   Xie Yan   Lin Ningjing   Tu Meifeng   Ping Lingyan   Ying Zhitao   Liu Weiping   Zhang Chen  

International Journal of Hematology, Vol. 98, Iss. 6, 2013-12 ,pp. : 664-671

Springer Publishing Company

Access to resources Recommend Favorite

Autologous bone marrow transplant in a patient with sickle cell disease and diffuse large B-cell lymphoma

By Onitilo A.A.   Lazarchick J.   Brunson C.Y.   Frei-Lahr D.   Stuart R.K.  

Transplantation Proceedings, Vol. 35, Iss. 8, 2003-12 ,pp. : 3089-3092

Elsevier

Access to resources Recommend Favorite

Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung

By Aviles Agustin   Nambo Maria J.   Huerta-Guzman Judith   Silva Luis   Neri Natividad  

Hematology, Vol. 18, Iss. 2, 2013-03 ,pp. : 81-84

Maney Publishing

Access to resources Recommend Favorite

Central nervous system manifestations of marginal zone B-cell lymphoma

By Bayraktar Soley   Stefanovic Alexandra   Montague Naomi   Davis Janet   Murray Timothy   Lossos Izidore  

Annals of Hematology, Vol. 89, Iss. 10, 2010-10 ,pp. : 1003-1009

Springer Publishing Company

Access to resources Recommend Favorite

Mutations in isocitrate dehydrogenase isoforms 1 and 2 are rare events in primary central nervous system and non-central nervous system diffuse large B cell lymphoma

By Noh Songmi   Park Eun Ju   Choi Junjeong   Lee Sarah   Jang Seon Jung   Kim Se Hoon  

Basic and Applied Pathology, Vol. 4, Iss. 2, 2011-06 ,pp. : 58-62

Blackwell Publishing

Access to resources Recommend Favorite